The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is one of the best future stocks to buy for the long term. On January 12, ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth-quarter 2025 ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $438.92, representing a -2.36% change from its previous ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, after the financial markets close. The company ...

Vertex Pharmaceuticals is anchored by cystic fibrosis as launches lag, JOURNAVX and CASGEVY add little revenue, and growth is ...

Fintel reports that on January 6, 2026, Wolfe Research upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from Peer Perform to Outperform. Analyst Price Forecast Suggests 11.64% Upside ...

Shares of Vertex Pharmaceuticals Inc. VRTX shed 2.36% to $438.92 Thursday, on what proved to be an all-around great trading ...

Detailed price information for Roche Holding Ltd (RHHVF) from The Globe and Mail including charting and trades.

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.